Goldman Sachs

Goldman Sachs’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Goldman Sachs’s Portfolio PRVL Stock Details PRVL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell
2020 Q4	$6.77M	Buy
2020 Q3	$575K	Buy
2020 Q2	$482K	Buy
2020 Q1	$252K	Buy
2019 Q4	$247K	Buy
2019 Q3	–	Sell
2019 Q2	$497K	Buy